Presentations

Filter by Category

All Blog Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

June 12, 2020-June 18, 2020

The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs

Presented at the DIA Virtual Global Annual Meeting, held June 12 – 18, 2020.

May 6, 2020

Webinar: What you want and need to know about the Rare Disease Cures Accelerator – Data and Analytics Platform (May 6, 2020)

April 27, 2020

Critical Path for Parkinson’s Consortium 3DT Initiative: Early regulatory engagement to optimize paths for efficient use of digital health technologies in PD clinical trials

A subset of CPP member organizations* have convened to collaborate precompetitively with the goal of optimizing the efficiency of

October 21, 2019

Towards EMA Qualification of Islet Auto-Antibodies as a Model-Based Clinical Trial Enrichment Platform for Type-1 Diabetes Prevention Studies

September 23, 2019

Enabling efficient use of digital health technologies to support Parkinson’s disease drug development through precompetitive collaboration

August 1, 2019

CPP 3DT Regulatory Interaction Summary August 2019

June 25, 2019

Best Practices for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials

June 3, 2019

Collaborative framework for delivering on ways that digital technologies can help to optimize new Parkinson’s treatment trials. Stephenson D …et al. | 5th World Parkinson Congress, Kyoto, Japan

May 22, 2019

Measurement Comparability of Electronic and Paper Administered Visual Analogue Scales: A Review of Published Studies

May 1, 2019

Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science. Stephenson D …et al. | American Academy of Neurology, Philadelphia, PA

Previous67 8...13 Next